Health Minister Nalinda Jayatissa clarified that the ongoing shortage of medicines in the country is not a result of financial difficulties but stems from procurement-related issues.
Speaking at a ceremony in Ampara, the Minister explained that procurement processes for medicine imports have already begun, with supplies expected to arrive after November.
He also pointed out that some medicines are currently unavailable in the private sector, including pharmacies.
“We do not permit registration at unlimited prices. A price range has been set based on the South Asian market situation. Those unwilling to comply with this pricing structure have refrained from supplying medicines,” the Minister said.
The State Pharmaceuticals Corporation (SPC) has been assigned to handle the procurement process, with 80–85% already completed, according to the Minister.
Addressing broader economic challenges, he added that the suspension of several development projects in recent years has placed an additional burden on the treasury.
“There are 17 projects in Sri Lanka awaiting resumption after being halted. These projects have already cost the treasury Rs. 59 billion, despite being scheduled for completion by 2018, 2020, or 2022. Completing them now will require an additional Rs. 29 billion,” Minister Jayatissa noted.
